Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Foot-and-Mouth Disease Virus Type A1 Antigen

Cat. No.VG6F34

Product TypeVeterinary Antigens

Size 1 mg

Product Overview

BioVenic's Recombinant Foot-and-Mouth Disease Virus Type A1 Antigen is a recombinant antigen produced by E.coli. This antigen has undergone a rigorous purification process. It can be used for ELISA plate coating or for the preparation of enzyme conjugates.

Specifications

Type Recombinant Protein
Species Virus
Expression System E. coli
Purification Immunoaffinity Chromatography Purified
Physical State Liquid or Lyophilized

Target Information

Foot-and-Mouth Disease Virus Type A1 is a historical and epidemiologically significant subtype/lineage of the Type A aphthovirus, an un-enveloped, positive-sense, single-stranded RNA virus affecting cloven-hoofed animals. It targets epithelial tissues, causing vesicular lesions. Because Type A viruses exhibit extreme antigenic drift, the hypervariable loops within the VP1 capsid protein-specifically the G-H loop containing the cell-binding RGD motif-are the primary targets for molecular tracking, strain-specific companion diagnostics, and matching tailored vaccine formulations.

Protein Recombinant Foot-and-Mouth Disease Virus Type A1 Antigen
Protein Synonym FMDV Serotype A Subtype 1; Aphthovirus A1; Foot and mouth disease virus A1 subtype; FMDV A1 lineage; FMDV A/1

Shipping and Storage

This product is shipped with gel ice bags. Store at 0-4°C for no more than 2 weeks, or -20°C or below for long-term storage.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
Inquiry Basket